watch and wait strategy

OTHER2 trials

Sponsors

Chiba University hospital, Sun Yat-sen University

Conditions

ChemoradiationRectal CancerRectal Cancer Stage IIRectal Cancer Stage IIIlow rectal cancer

Phase 2

TNT to Increase the Clinical Complete Response Rate for Distal LARC

Active, not recruitingNCT03840239

Sun Yat-sen UniversityChemoradiation, Rectal Cancer, Rectal Cancer Stage II +1

Start: 2018-12-25End: 2027-06-30Target: 98Updated: 2023-10-25

Unknown Phase

Organ preserving strategy "Watch and Wait" for rectal adenocarcinoma acheived clinical complete response treated with chemoradiotherapy

RecruitingJPRN-UMIN000037206

Chiba University hospitallow rectal cancer

Start: 2019-10-01Target: 15Updated: 2026-06-29

Related Papers

Safety and Efficacy of a Sandwich Total Neoadjuvant Therapy Strategy for Low‐Risk Distal Locally Advanced Rectal Cancer: Results From the TESS Phase II Trial

MedComm2026-06-17

Total neoadjuvant treatment versus standard chemoradiation to increase the sphincter preservation rate for distal locally advanced rectal cancer (TESS).

Journal of Clinical Oncology2021-05-201 citations